Investors have filed securities class actions against Ardelyx, alleging the company misrepresented the outlook for IBSRELA and XPHOZAH while payer restrictions hindered access and prescription growth. The suits follow Ardelyx’s lowered IBSRELA revenue forecast and withdrawal of long-term XPHOZAH guidance, after which its shares fell sharply; investors have until November 16, 2026, to seek lead-plaintiff status.

Finance· 1d

Facts from Wikidata (CC0).

tenapanor

chemical compound

0members1here now

Ask Genius Site

Site Journal

Feed Discussions About

Sort by

Content type

Latest tenapanor news and discussion

Sort by

Content type

Ttenapanor· Finance · 6 sources · 1dStory

Securities Suit Filed Against Ardelyx Over Alleged Fraud

Finance· 1d

Facts from Wikidata (CC0).

tenapanor across IJR

Ask Genius by OpenServe about tenapanor Create in Studio Build a game Watch videos

About tenapanor

chemical compound

members

here now

Coverage spread L41 / C33 / R26

Everything about tenapanor →

Live room · 1 here

Be the first in the room — members see you arrive.

Join the room

tenapanor across IJR

Ask Genius by OpenServe about tenapanor Create in Studio Build a game Watch videos